Results 191 to 200 of about 4,754 (217)

Chemotherapy of Mediterranean Visceral Leishmaniasis with Meglumine Antimoniate

1989
Over the last years many trials have been performed to obtain adequate new drug delivery systems which could carry drugs directly to macrophages. In such systems, liposome [1] or cell ghosts [2] could carry smaller amounts of conventional drugs with a high efficacy and obviously lower toxicity. However, they are as yet only experimental systems.
Luis Tavares, Celia Carvalho, Eduardo Monteiro   +2 more
openaire   +1 more source

Localized leishmaniasis treated with intralesional meglumine antimoniate

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2020
Uriel, Villela-Segura, Héctor, Proy-Trujillo, Ixtabay, Ilizaliturri-Flores, Victor Javier, Leal-Ascencio, Nixma, Eljure-López   +4 more
openaire   +2 more sources

Meglumine antimoniate

Reactions Weekly, 1996
openaire   +1 more source

Meglumine antimoniate

Reactions Weekly, 2000
openaire   +1 more source

Intralesional treatment of cutaneous leishmaniasis with meglumine antimoniate

British Journal of Dermatology, 1998
Aste N, Pau M, FERRELI, CATERINA, Biggio P.   +3 more
openaire   +3 more sources

Meglumine antimoniate

Reactions Weekly, 2017
openaire   +1 more source

Meglumine antimoniate interaction

Reactions Weekly, 2000
openaire   +1 more source

Meglumine antimoniate/sodium stibogluconate

Reactions Weekly, 1995
openaire   +1 more source

Meglumine antimoniate

Reactions Weekly, 2013
openaire   +1 more source

Administration of Miltefosine and Meglumine Antimoniate in Healthy Dogs: Clinicopathological Evaluation of the Impact on the Kidneys

Toxicologic Pathology, 2009
Marialuisa Valente, Luca Aresu, Laura Cavicchioli   +2 more
exaly